BRC News

Researchers are set to carry out a large-scale, global study of a ground-breaking Huntington’s disease drug which is the first in the world to lower the level of the harmful huntingtin protein which causes Huntington’s.

Researchers are testing whether a new device developed at UCL that measures oxygen levels in the bladder wall can act as an early warning of deterioration in critically ill patients and those undergoing high-risk surgery.

UCL ranks second in the world and top in Europe for the number of inventions and patent applications made in relation to the revolutionary new cancer treatment CAR T-cell therapy – key markers of CAR T research activity at UCL and UCLH.

Thanks to a £1 million grant, space technology could improve the early detection and diagnosis of bowel cancer in a trial to be carried out at UCH.

A team from UCLH and UCL has seen off competition from 120 applicants to have its research paper crowned as the best of the year.

A team from University College London Hospitals (UCLH), UCL and Great Ormond Street Hospital (GOSH) has won the clinical leadership team award in the BMJ awards.

Some people may be more genetically prone to cannabis addiction, a study led by UCL has found.

Researchers have identified a genetic defect as a common cause of late-onset ataxia meaning many patients can receive a definite diagnosis and treatment can be improved.

Close to one in two cases of dementia could be preventable in low- to middle-income countries, a UCL study has found.

Researchers at UCLH and UCL have developed artificial intelligence to predict which patients are most likely to miss appointments.

Researchers are considering how best to support patients who have posttraumatic stress disorder (PTSD) after spending time in the intensive care unit (ICU).

The BRC has today launched an animated film for GCSE and A level students on CAR T-cell therapy – a revolutionary approach to the treatment of cancer in development at UCL and UCLH.

Researchers have developed a blood test which is ten times more effective than the current test for predicting whether a person exposed to tuberculosis (TB) will go on to develop the TB themselves.

UCLH is to have Europe’s first dedicated cellular immunotherapy research and treatment centre.

Chronic stroke patients continue to benefit from intensive rehabilitation over a much longer period than previously thought, a UCL-led study has found. The finding could have “huge implications” for future treatments.